FY 2004 Grant Opportunity
Downloadable files |
Department of Health and Human Services
|
|
Notice of Funding Availability (NOFA) |
||
Download NOFA
|
Funding Opportunity Title: Drug-Addiction-Treatment-Act-of-2000 (DATA)
|
|
Announcement Type: Initial |
Funding Opportunity Number: TI 04-005 |
|
Catalog of Federal Domestic Assistance (CFDA) Number: 93.243 |
||
Scroll down for more links |
Due Date for Applications: June 2, 2004 |
|
[Note: Letters from State Single Point of Contact (SPOC) in response to E.O. 12372 are due August 1, 2004.] |
||
SUMMARY:The Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Substance Abuse Treatment (CSAT), announces the availability of FY 2004 funds for the Drug-Addiction-Treatment-Act-of-2000 (DATA) (Title XXXV of the Children's Health Act of 2000) Physician Clinical Support System (Short Title: DATA Physician Clinical Support System). A synopsis of this funding opportunity, as well as many other Federal Government funding opportunities, is also available at the Internet site: www.grants.gov. |
||
Download Standard Announcement |
For complete instructions, potential applicants must obtain a copy of SAMHSA's standard Infrastructure Grants Program Announcement (INF-04 PA [MOD]), and the PHS 5161-1 (Rev. 7/00) application form before preparing and submitting an application. The INF-04 PA [MOD] describes the general program design and provides instructions for applying for all SAMHSA Infrastructure Grants, ncluding the DATA Physician Clinical Support System. SAMHSA's Infrastructure Grants provide funds to increase the capacity of mental health and/or substance abuse service systems to support effective programs and services. Additional instructions and specific requirements for this funding opportunity are described below. |
|
I. Funding Opportunity DescriptionAUTHORITY: : Section 509 of the Public Health Service Act, as amended, and subject to the availability of funds The purpose of the DATA Physician Clinical Support System cooperative
agreement is to develop a coordinated, clinical support program for physicians
who are treating addicted patients with buprenorphine products.
End of Applicants are expected to develop a coherent, well-designed program to assist physicians in developing the skills and confidence to treat addicted patients, thereby reducing resistance and barriers to the availability of treatment. By enlisting the assistance of professional medical groups and other organizations, the grantee will offer physicians the information and consultation they need to provide safe and effective buprenorphine treatment. |
||
Applicants must select activities from the following list of infrastructure development activities, as appropriate to their proposed project:
|
||
Applicants must demonstrate the ability to provide consultative services, telephone consultation, on-site training, observation of practice, and peer mentoring to physicians treating patients for opioid addiction. Applicants may propose other activities, such as conducting a limited number of regional meetings or online Web conferences to improve physician workforce performance. Physician support activities must focus on the following content areas:
|
||
Background:
The need for medication-assisted treatment for opioid addiction greatly exceeds the Nation's treatment capacity. To address this long-standing problem, the Drug Addiction Treatment Act of 2000 (DATA) was enacted to allow trained, qualified physicians to prescribe specifically approved narcotic medications for the treatment of opioid addiction in their offices or settings outside traditional opioid treatment programs. The Food and Drug Administration approved two brand-name medications containing buprenorphine for this treatment in 2002. SAMHSA was assigned responsibility to assist with training physicians under DATA. Approximately 4,000 physicians have been trained and 2,500 are approved to prescribe these medications. Yet, the stigma of addiction tends to discourage primary care physicians from obtaining training and treating this population. Also, the lack of physician experience, concerns over practical issues, and limited understanding of the appropriate role of medication in opioid treatment all appear to be factors in the slow adoption of this form of treatment intervention by the medical profession. |
||
II. Award Information
|
||
|
||
|
||
III. Eligibility Information
|
||
Go
to Application forms:
and |
IV. Application and Submission Information:
|
|
|
||
|
||
Checklist for Formatting Requirements and Screenout Criteria for SAMHSA Grant Applications |
||
SAMHSA's goal is to review all applications submitted for grant funding. However, this goal must be balanced against SAMHSA's obligation to ensure equitable treatment of applications. For this reason, SAMHSA has established certain formatting requirements for its applications. If you do not adhere to these requirements, your application will be screened out and returned to you without review. |
||
Use the PHS 5161-1 application. | ||
Applications must be received by the application deadline. Applications received after this date must have a proof of mailing date from the carrier dated at least 1 week prior to the due date. Private metered postmarks are not acceptable as proof of timely mailing. Applications not received by the application deadline or not postmarked at least 1 week prior to the application deadline will not be reviewed. | ||
Information provided must be sufficient for review. | ||
Text must be legible.
|
||
Paper must be white paper and 8.5 inches by 11.0 inches in size. | ||
To ensure equity among applications, the amount of space allowed for the Project Narrative cannot be exceeded.
|
||
The page limit for Appendices stated in the specific funding announcement cannot be exceeded. | ||
To facilitate review of your application, follow these additional guidelines. Failure to adhere to the following guidelines will not, in itself, result in your application being screened out and returned without review. However, the information provided in your application must be sufficient for review. Following these guidelines will help ensure your application is complete, and will help reviewers to consider your application. | ||
The 10 application components required for SAMHSA applications must be included:
|
||
Applications should comply with
the following requirements:
|
||
Pages should be typed single-spaced with one column per page. | ||
Pages should not have printing on both sides. | ||
Please use black ink, and number pages consecutively from beginning to end so that information can be located easily during review of the application. The cover page should be page 1, the abstract page should be page 2, and the table of contents page should be page 3. Appendices should be labeled and separated from the Project Narrative and budget section, and the pages should be numbered to continue the sequence. | ||
Send the original application and two copies to the mailing address in the funding announcement. Please do not use staples, paper clips, and fasteners. Nothing should be attached, stapled, folded, or pasted. Do not use heavy or lightweight paper, or any material that cannot be copied using automatic copying machines. Odd-sized and oversized attachments such as posters will not be copied or sent to reviewers. Do not include videotapes, audiotapes, or CD-ROMs. | ||
|
||
|
||
|
||
V. Application Review Information
|
||
|
||
|
||
|
||
|
||
|
||
|
||
VI. Award Administration Information:Award administration information, including award notices, administrative and national policy requirements, and reporting requirements are available in the INF-04 PA [MOD] in Section VI. SAMHSA's standard terms and conditions are available at Information on the Grant Application Process. |
||
Agency Contact for Additional Information:For questions concerning program issues, contact: Raymond Hylton, RN, MSN, For questions on grants management issues, contact: Kathleen
Sample, |
||
Dated: |
Signed: |